Medicine guide
Tritanrix HepB
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed)
- Made by
- GlaxoSmithKline Biologicals S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Tritanrix HepB is indicated for active immunisation against diphtheria, tetanus, pertussis and hepatitis B (HBV) in infants from six weeks onwards (see section 4.2).
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | GlaxoSmithKline Biologicals S.A. |
|---|---|
| Active substance | Diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07CA05 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 1996-07-19 |
| Last updated by the regulator | 2014-01-07 |
| EMA product number | EMEA/H/C/000093 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).